Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial improvement in negative schizophrenic symptoms after amphetamine.

B Angrist, E Peselow, M Rubinstein

    Psychopharmacology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An Arabidopsis gene regulatory network for secondary cell wall synthesis.

    Nature·2014
    Same author

    Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.

    Psychoneuroendocrinology·2014
    Same author

    Heroin addiction in African Americans: a hypothesis-driven association study.

    Genes, brain, and behavior·2009
    Same author

    Genetic susceptibility to heroin addiction: a candidate gene association study.

    Genes, brain, and behavior·2008
    Same author

    Attention-deficit/hyperactivity disorder in adult patients with posttraumatic stress disorder (PTSD): is ADHD a vulnerability factor?

    Journal of attention disorders·2005
    Same author

    Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.

    Archives of general psychiatry·2003

    Amphetamine partially reduced negative symptoms in stable schizophrenia patients. This suggests dopamine hypofunction may contribute to the schizophrenic defect state.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Schizophrenia is characterized by positive and negative symptoms.
    • Negative symptoms, or the "defect state," are persistent and difficult to treat.
    • The role of dopamine in schizophrenia pathophysiology is complex and debated.

    Purpose of the Study:

    • To investigate the effect of amphetamine on negative symptoms in stable schizophrenic outpatients.
    • To explore the hypothesis that dopaminergic hypofunction contributes to the schizophrenic defect state.

    Main Methods:

    • Administered amphetamine to stable schizophrenic outpatients with predominant negative symptoms.
    • Assessed the statistical significance and clinical discernibility of symptom changes.

    Related Experiment Videos

    Main Results:

    • Amphetamine caused a statistically significant reduction in negative symptoms.
    • The reduction was not complete, with symptoms remaining clinically discernible.
    • Limited data supports the concept of dopaminergic hypofunction in the schizophrenic defect state.

    Conclusions:

    • Amphetamine shows potential for alleviating negative symptoms in schizophrenia.
    • Dopaminergic hypofunction is a plausible contributing factor to the schizophrenic defect state.
    • Further research is warranted to explore dopamine's role in schizophrenia psychopathology.